Works matching AU van Schaik, Ron H. N.


Results: 71
    1
    2
    3
    4

    Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer.

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3179, doi. 10.3390/cancers12113179
    By:
    • Steendam, Christi M. J.;
    • Veerman, G. D. Marijn;
    • Pruis, Melinda A.;
    • Atmodimedjo, Peggy;
    • Paats, Marthe S.;
    • van der Leest, Cor;
    • von der Thüsen, Jan H.;
    • Yick, David C. Y.;
    • Oomen-de Hoop, Esther;
    • Koolen, Stijn L. W.;
    • Dinjens, Winand N. M.;
    • van Schaik, Ron H. N.;
    • Mathijssen, Ron H. J.;
    • Aerts, Joachim G. J. V.;
    • Dubbink, Hendrikus Jan;
    • Dingemans, Anne-Marie C.
    Publication type:
    Article
    5
    6
    7
    8
    9

    Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for UGT1A1*28 Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study.

    Published in:
    Oncologist, 2006, v. 11, n. 8, p. 944, doi. 10.1634/theoncologist.11-8-944
    By:
    • DE JONG, FLORIS A.;
    • KEHRER, DIEDERIK F. S.;
    • MATHIJSSEN, RON H. J.;
    • CREEMERS, GEERT-JAN;
    • DE BRUIJN, PETER;
    • VAN SCHAIK, RON H. N.;
    • PLANTING, ANDRÉ S. TH.;
    • VAN DER GAAST, ATE;
    • ESKENS, FERRY A. L. M.;
    • JANSSEN, JOS TH. P.;
    • RUIT, JAN B.;
    • VERWEIJ, JAAP;
    • SPARREBOOM, ALEX;
    • DE JONGE, MAJA J. A.
    Publication type:
    Article
    10

    Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients.

    Published in:
    Biomedicines, 2022, v. 10, n. 4, p. 896, doi. 10.3390/biomedicines10040896
    By:
    • Berends, Annika M. A.;
    • Bolhuis, Mathieu S.;
    • Nolte, Ilja M.;
    • Buitenwerf, Edward;
    • Links, Thera P.;
    • Timmers, Henri J. L. M.;
    • Feelders, Richard A.;
    • Eekhoff, Elisabeth M. W.;
    • Corssmit, Eleonora P. M.;
    • Bisschop, Peter H.;
    • Haak, Harm R.;
    • van Schaik, Ron H. N.;
    • el Bouazzaoui, Samira;
    • Wilffert, Bob;
    • Kerstens, Michiel N.
    Publication type:
    Article
    11

    Nucleic acid reference materials (NARMs): definitions and issues.

    Published in:
    Clinical Chemistry & Laboratory Medicine, 2010, v. 48, n. 11, p. 1531, doi. 10.1515/CCLM.2010.313
    By:
    • Payne, Deborah A.;
    • Mamotte, Cyril D. S.;
    • Gancberg, David;
    • Pazzagli, Mario;
    • van Schaik, Ron H. N.;
    • Schimmel, Heinz;
    • Rousseau, Francois
    Publication type:
    Article
    12

    Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211033704
    By:
    • van der Sijde, Fleur;
    • Azmani, Zakia;
    • Besselink, Marc G.;
    • Bonsing, Bert A.;
    • de Groot, Jan Willem B.;
    • Groot Koerkamp, Bas;
    • Haberkorn, Brigitte C. M.;
    • Homs, Marjolein Y. V.;
    • van IJcken, Wilfred F. J.;
    • Janssen, Quisette P.;
    • Lolkema, Martijn P.;
    • Luelmo, Saskia A. C.;
    • Mekenkamp, Leonie J. M.;
    • Mustafa, Dana A. M.;
    • van Schaik, Ron H. N.;
    • Wilmink, Johanna W.;
    • Vietsch, Eveline E.;
    • van Eijck, Casper H. J.
    Publication type:
    Article
    13
    14

    Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221081075
    By:
    • Buck, Stefan A. J.;
    • Braal, C. Louwrens;
    • Hofman, Maaike M.;
    • Oomen-de Hoop, Esther;
    • Bruijn, Peter de;
    • Ghobadi Moghaddam-Helmantel, Inge M.;
    • Hussaarts, Koen G. A. M.;
    • Vastbinder, Mijntje B.;
    • van Rossum-Schornagel, Quirine C.;
    • van Schaik, Ron H. N.;
    • Jager, Agnes;
    • Koolen, Stijn L. W.;
    • Mathijssen, Ron H. J.
    Publication type:
    Article
    15

    Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211033704
    By:
    • van der Sijde, Fleur;
    • Azmani, Zakia;
    • Besselink, Marc G.;
    • Bonsing, Bert A.;
    • de Groot, Jan Willem B.;
    • Groot Koerkamp, Bas;
    • Haberkorn, Brigitte C. M.;
    • Homs, Marjolein Y. V.;
    • van IJcken, Wilfred F. J.;
    • Janssen, Quisette P.;
    • Lolkema, Martijn P.;
    • Luelmo, Saskia A. C.;
    • Mekenkamp, Leonie J. M.;
    • Mustafa, Dana A. M.;
    • van Schaik, Ron H. N.;
    • Wilmink, Johanna W.;
    • Vietsch, Eveline E.;
    • van Eijck, Casper H. J.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF Consortium.

    Published in:
    Clinical Chemistry & Laboratory Medicine, 2018, v. 56, n. 4, p. e83, doi. 10.1515/cclm-2017-0838
    By:
    • Stathopoulou, Maria G.;
    • Ting Xie;
    • Ruggiero, Daniela;
    • Chatelin, Jerome;
    • Rancier, Marc;
    • Weryha, George;
    • Jo Kurth, Mary;
    • Arguinano, Alex-Ander Aldasoro;
    • Gorenjak, Vesna;
    • Petrelis, Alexandros M.;
    • Dagher, Georges;
    • Dedoussis, George;
    • Deloukas, Panagiotis;
    • Lamont, John;
    • Marc, Janja;
    • Simmaco, Maurizio;
    • van Schaik, Ron H. N.;
    • Innocenti, Federico;
    • Merlin, Jean-Louis;
    • Schneider, Jochen
    Publication type:
    Article
    29
    30
    31
    32
    33
    34

    Towards precision dosing of aripiprazole in children and adolescents with autism spectrum disorder: Linking blood levels to weight gain and effectiveness.

    Published in:
    British Journal of Clinical Pharmacology, 2023, v. 89, n. 10, p. 3026, doi. 10.1111/bcp.15800
    By:
    • Hermans, Rebecca A.;
    • Sassen, Sebastiaan D. T.;
    • Kloosterboer, Sanne Maartje;
    • Reichart, Catrien G.;
    • Kouijzer, Mirjam E. J.;
    • de Kroon, Matthias M. J.;
    • Bastiaansen, Dennis;
    • van Altena, Daphne;
    • van Schaik, Ron H. N.;
    • Nasserinejad, Kazem;
    • Hillegers, Manon H. J.;
    • Koch, Birgit C. P.;
    • Dierckx, Bram;
    • de Winter, Brenda C. M.
    Publication type:
    Article
    35
    36
    37

    Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1.

    Published in:
    Clinical Pharmacokinetics, 2023, v. 62, n. 11, p. 1589, doi. 10.1007/s40262-023-01279-7
    By:
    • de With, Mirjam;
    • van Doorn, Leni;
    • Kloet, Esmay;
    • van Veggel, Anne;
    • Matic, Maja;
    • de Neijs, Micha J.;
    • Oomen - de Hoop, Esther;
    • van Meerten, Esther;
    • van Schaik, Ron H. N.;
    • Mathijssen, Ron H. J.;
    • Bins, Sander
    Publication type:
    Article
    38

    CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients.

    Published in:
    Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1129, doi. 10.1007/s40262-023-01260-4
    By:
    • van Eerden, Ruben A. G.;
    • IJzerman, Nikki S.;
    • van Meekeren, Milan;
    • Oomen-de Hoop, Esther;
    • Guchelaar, Niels A. D.;
    • Visser, Andrea M. W.;
    • Matic, Maja;
    • van Schaik, Ron H. N.;
    • de Bruijn, Peter;
    • Moes, Dirk-Jan A. R.;
    • Jobse, Pieter A.;
    • Gelderblom, Hans;
    • Huitema, Alwin D. R.;
    • Steeghs, Neeltje;
    • Mathijssen, Ron H. J.;
    • Koolen, Stijn L. W.
    Publication type:
    Article
    39

    Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients.

    Published in:
    2019
    By:
    • Bins, Sander;
    • Huitema, Alwin D. R.;
    • Laven, Pim;
    • Bouazzaoui, Samira el;
    • Yu, Huixin;
    • van Erp, Nielka;
    • van Herpen, Carla;
    • Hamberg, Paul;
    • Gelderblom, Hans;
    • Steeghs, Neeltje;
    • Sleijfer, Stefan;
    • van Schaik, Ron H. N.;
    • Mathijssen, Ron H. J.;
    • Koolen, Stijn L. W.
    Publication type:
    journal article
    40
    41
    42
    43
    44
    45

    Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy.

    Published in:
    Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 939, doi. 10.1002/cpt.3351
    By:
    • Duarte, Julio D.;
    • Thomas, Cameron D.;
    • Lee, Craig R.;
    • Huddart, Rachel;
    • Agundez, Jose A. G.;
    • Baye, Jordan F.;
    • Gaedigk, Andrea;
    • Klein, Teri E.;
    • Lanfear, David E.;
    • Monte, Andrew A.;
    • Nagy, Mohamed;
    • Schwab, Matthias;
    • Stein, C. Michael;
    • Uppugunduri, Chakradhara Rao S.;
    • van Schaik, Ron H. N.;
    • Donnelly, Roseann S.;
    • Caudle, Kelly E.;
    • Luzum, Jasmine A.
    Publication type:
    Article
    46
    47

    PharmVar GeneFocus: CYP3A5.

    Published in:
    Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1159, doi. 10.1002/cpt.2563
    By:
    • Rodriguez‐Antona, Cristina;
    • Savieo, Jessica L.;
    • Lauschke, Volker M.;
    • Sangkuhl, Katrin;
    • Drögemöller, Britt I.;
    • Wang, Danxin;
    • van Schaik, Ron H. N.;
    • Gilep, Andrei A.;
    • Peter, Arul P.;
    • Boone, Erin C.;
    • Ramey, Bronwyn E.;
    • Klein, Teri E.;
    • Whirl‐Carrillo, Michelle;
    • Pratt, Victoria M.;
    • Gaedigk, Andrea
    Publication type:
    Article
    48
    49

    Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study.

    Published in:
    Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 1, p. 62, doi. 10.1002/cpt.2608
    By:
    • de With, Mirjam;
    • Knikman, Jonathan;
    • de Man, Femke M.;
    • Lunenburg, Carin A. T. C.;
    • Henricks, Linda M.;
    • van Kuilenburg, André B. P.;
    • Maring, Jan G.;
    • van Staveren, Maurice C.;
    • de Vries, Niels;
    • Rosing, Hilde;
    • Beijnen, Jos H.;
    • Pluim, Dick;
    • Modak, Anil;
    • Imholz, Alex L. T.;
    • van Schaik, Ron H. N.;
    • Schellens, Jan H. M.;
    • Gelderblom, Hans;
    • Cats, Annemieke;
    • Guchelaar, Henk‐Jan;
    • Mathijssen, Ron H. J.
    Publication type:
    Article
    50

    Pharmacogenetic Information in Clinical Guidelines: The European Perspective.

    Published in:
    Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 5, p. 795, doi. 10.1002/cpt.1049
    By:
    • Swen, Jesse J.;
    • Nijenhuis, Marga;
    • Van Rhenen, Mandy;
    • De Boer‐veger, Nienke J.;
    • Buunk, Anne‐marie;
    • Houwink, Elisa J. F.;
    • Mulder, Hans;
    • Rongen, Gerard A.;
    • Van Schaik, Ron H. N.;
    • Van Der Weide, Jan;
    • Wilffert, Bob;
    • Deneer, Vera H. M.;
    • Guchelaar, Henk‐jan;
    • On Behalf Of The Dutch Pharmacogenetics Working Group (dpwg) Of The Royal Dutch Pharmacists Association (knmp)
    Publication type:
    Article